Theranos Agrees to Two Year Ban, Refunds Every Arizonan Who Purchased a Blood Test
By Zachary Brennan -
Published 18 April 2017
As part of an agreement reached with Arizona attorney general Mark Brnovich, the medical device startup Theranos on Tuesday agreed to pay $4.65 million for about 1.5 million blood tests sold to more than 175,000 Arizonans.
Categories: News, US, Compliance, Crisis management, In vitro diagnostics, Medical Devices
Tags: Theranos, blood test, Arizona, CMS